Vimarsana
Biggest News Aggregation in the World

Page 10 - Programme For Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Programme For Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Programme For Research Today - Breaking & Trending Today

Stephen Lawn Memorial Lecture 2022 - Vimarsana News

Stephen Lawn Memorial Lecture 2022

Lessons from COVID-19: How to accelerate Tuberculosis research

GHTC statement to the WHO Executive Board on tuberculosis research - Vimarsana News

GHTC statement to the WHO Executive Board on tuberculosis research

In advance of the 150th session of the World Health Organization (WHO) Executive Board, GHTC is calling on WHO and member states to increase investments in tuberculosis (TB) R&D, enhance protocol coordination and data sharing platforms, and streamline guidance processes for new tools to accelerate the development of and equitable access to TB products.

IIHMR University, Jaipur selected globally for second phase of TDR Postgraduate Training Scheme to train the next generation of public health leaders - Vimarsana News

IIHMR University, Jaipur selected globally for second phase of TDR Postgraduate Training Scheme to train the next generation of public health leaders

Jaipur: IIHMR University, Jaipur has been selected from India to implement the second phase of TDR’s Postgraduate Training Scheme (2022-2026). TDR’s Postgraduate Training Scheme will provide a full academic scholarship though IIHMR University for sel

Swiss-EU relations and research: what's next? - Vimarsana News

Swiss-EU relations and research: what's next?

Switzerland’s research position depends on links to key European funding programmes. Where does the country stand given the latest EU developments?

WHO guidance weighs risks, rewards of GM mosquitoes - Vimarsana News

WHO guidance weighs risks, rewards of GM mosquitoes

Genetically modified (GM) mosquitoes are touted as the answer to dengue and malaria, but questions remain over safety and ethics.

Source: scidev.net